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ABSTRACT A hallmark feature of prions, whether in mammals or yeast and fungi, is exponential growth associated with
ﬁssion or autocatalysis of protein aggregates. We have employed a rigorous kinetic analysis to recent data from transgenic
mice lacking a glycosylphosphatidylinositol membrane anchor to the normal cellular PrPC protein, which show that toxicity
requires the membrane binding. We ﬁnd as well that the membrane is necessary for exponential growth of prion aggregates;
without it, the kinetics is simply the quadratic-in-time growth characteristic of linear elongation as observed frequently in in vitro
amyloid growth experiments with other proteins. This requires both: i), a substantial intercellular concentration of anchorless
PrPC, and ii), a concentration of small scrapies seeding aggregates from the inoculum, which remains relatively constant with
time and exceeds the concentration of large polymeric aggregates. We also can explain via this analysis why mice
heterozygous for the anchor-full/anchor-free PrPC proteins have more rapid incubation than mice heterozygous for anchor-full/
null PrPC, and contrast the mammalian membrane associated ﬁssion or autocatalysis with the membrane free ﬁssion of yeast
and fungal prions.
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Prions are distinguished from other amyloid diseases both
by their infectious character and the observed exponential
growth of infectious material in vivo (1). There is a corre-
spondence to this of prion-like proteins in yeast and fungi,
for which spontaneous ﬁssion is reported in vitro (2). In fact,
it has been argued that the replication necessary for infection
in mammals and non-Mendelian inheritance in yeast/fungi
requires the ﬁssion or autocatalysis that drives the exponen-
tial growth (1). It has been established for yeast prions that
additional chaperone proteins most likely facilitate the ﬁs-
sion of aggregates in living cells (1). It is an open question
what mechanism drives the exponential growth in mammals.
Here we show by a rigorous kinetic analysis of recent disease
time course data that the exponential growth is tied to mem-
brane anchoring of the prion protein, suggesting that either
mechanical ﬁssion of areal prion aggregates or oligomeric
autocatalysis of membrane bound prions explain the ob-
served behavior.
Chesebro et al. (3) recently studied transgenic (Tg) mice
lacking a GPI membrane anchor to the normal cellular PrPC
protein and discovered that these mice grew infectious prions
without suffering neuronal death. We denote these anchor-
less cellular prions as PrPCTg; and anchor-full wild-type (WT)
cellular prions by PrPCWT: When inoculated with infectious
scrapies prions (PrPSc) at a dose that induces clinical symp-
toms within 140–160 days for WT mice, the Tg mice were
symptomless up to 400–600 days, even though proteinase
resistant PrP-res, an indicator of infectivity, accumulated and
surpassed the maximal WT levels.
In Fig. 1 the Tg mice PrP-res concentration (crosses) of
Chesebro et al. (3) are plotted versus the square of time, together
with a linear regression ﬁt (line) with a high regression
coefﬁcient (R ¼ 0.97). This time dependence is consistent
with short time kinetics described by linear polymer elon-
gation via monomer addition without ﬁssion or autocatalysis
(4), illustrated schematically in Fig. 2. Assuming the PrP-res
concentration to be a proxy for the total protein content in
aggregate, simple kinetic arguments predict a behavior, before
monomer depletion and seed nucleus depletion, of
½PrP-resðtÞ} ð1=2Þðp1 ½PrPCTgÞ2½PrPScn  t2; (1)
with p1½PrPCTg the elongation rate at intercellular monomer
Tg prion concentration [PrPCTg], and [PrP
Sc
n ] is the intercel-
lular concentration of seeding nuclei from inoculated scra-
pies protein after initial hydrodynamic clearance. The
validity of Eq. 1 at long times suggests that: i), there is a
substantial homeostatic concentration of intercellular PrPCTg
presumably due to slow clearance, and ii), [PrPScn ] is hardly
changed implying either that only a small fraction of seeds
grow into large polymers or [PrPScn ] is maintained by steady
proteolytic degradation of large remnant aggregates from the
dose. Given a similar de novo production rate of PrPCWT in
inoculated WT mice, we speculate that the associated sat-
uration of [PrP-res] arises from loss of PrPCWT after cell death.
This elongation hypothesis is testable by: i), genetically
engineering mice to overexpress PrPCTg; which will quadrat-
ically modulate the PrP-res concentration (4), and ii), by
varying the initial dose of PrPSc, which will linearly mod-
ulate the PrP-res concentration.
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Another striking observation of Chesebro et al. (3) was
that mice heterozygous for expression of PrPCTg and PrP
C
WT
display shorter incubation time upon inoculation than mice
with one PrPCWT copy and one inactive fusion construct. We
argue that this is due to an enhanced concentration for PrPCTg
relative to PrPCWT and that PrP-res obtained from PrP
C
Tg also
templates PrPCWT conversion. The latter is speculative but
should be testable.
To establish the expectation that the PrPCWT concentration
is lower than PrPCTg in the WT/Tg heterozygotes, it is suf-
ﬁcient to establish that PrPCWT concentration in WT mice is
lower than PrPCTg concentration in the anchorless Tg mice. To
make this clear, we compare estimates for cellular prion
concentrations in homozygous WT mice with homozygous
Tg mice. Before the postulated cell-death driven saturation
of infectious material, WT mice inoculated with a concen-
tration [PrPScn ] of scrapies seeds will have a time course of the
general form (4)
½PrP-resðtÞ}A1 ðcosh½lt  1Þ; (2)
where l ¼ ln(2)/t2 is the percentage growth rate and t2 is the
doubling time. The coefﬁcient A1 can be determined from
the short time behavior of Eq. 2, which, like Eq. 1, is
described by linear elongation given by
1=2A1 ðltÞ2 ¼ 1=2 ðp1 ½PrPCWTÞ2½PrPScn t2; (3)
where [PrPCWT] is the homeostatic concentration of mem-
brane boundWT PrPC and we have assumed that the WT and
Tg mice have the same PrP-res elongation coefﬁcient p1.
On the other hand, at long times (but before saturation)
Eq. 2 gives
½PrP-resðtÞ} 1=2A1 expðltÞ: (4)
Now, we set t1 ¼ N1d t2 as the time it takes WT mice to
reach clinically detectable levels of PrP-res concentration at
the inoculum level generating a seed nuclei concentration
[PrPScn ], where N
1
d is the number of doublings experienced in
that process, and t is the time it takes Tg mice to reach the
same clinical concentration of PrP-res for the same initial in-
oculation dose. By taking suitable ratios to eliminate A1,
[PrPScn ], and p1, the ratio of homeostatic concentrations of
cellular prions from the WT mice to the Tg mice is given by
½PrPCWT=½PrPCTg ¼ ð1=2Þlnð2ÞN1d ðt=t1 Þ
3 expðlnð2ÞðN1d =2ÞÞ:
(5)
From Chesebro et al. (3), t1 ¼ 150 days, and t ¼ 400
days. A reasonable estimate (5) for the number of doublings
is N1d ¼ 20 for the dose of Chien et al. (1). With these
numbers, Eq. 5 gives a concentration ratio (and hence
elongation rate ratio) for WT/Tg mice of 0.036. This is
reasonable given that likely slower PrPC clearance in the Tg
case will lead to a higher extracellular concentration of
cellular prion protein. By employing the arguments of Chien
et al. (1) we obtain elongation rate values of 0.13/day(Wt)
and 3.5/day (Tg). The former is in good agreement with es-
timates made elsewhere for linear elongation based upon
analysis of dose-incubation curves (6).
Hence, in the WT/Tg and WT/null heterozygotes explored
in Chesebro et al. (3), we anticipate in each case the mem-
brane bound PrPCWT concentration to be about half that of the
homozygous WT mice, whereas the intercellular PrPCTg
concentration should be about half that of the homozygous
Tg mice. Because, as shown with infectious prions bound
to electrodes (7), templating and conversion can be driven
by scrapies material not bound to the membrane surface, we
expect the incubation time of the WT/Tg heterozygotes to be
signiﬁcantly accelerated relative to the WT/null heterozy-
gotes as is observed.
We note that membrane associated exponential growth
might be due to: i), as yet undiscovered membrane speciﬁc
enzymes splitting aggregates, in analogy to the role of
Hp104a for yeast prions (1); ii),mechanical breakage of aggre-
gates due to membrane curvature or membrane undulations
(8); iii), oligomeric autocatalysis arising from interneuronal
FIGURE 1 Quadratic-in-time ﬁt to infectious prion time course
data of Chesebro et al. (3).
FIGURE 2 Schematicmodel for linear elongation driven growth
of infectious prion material from inoculated seeds and anchor-
less cellular prion proteins.
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templating by infectious oligomeric seeds bound to one or the
other membrane (9).
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